(Stroke. 2001;32:561.)
© 2001 American Heart Association, Inc.
Original Contributions |
Caspase Inhibitors Attenuate Oxyhemoglobin-Induced Apoptosis in Endothelial Cells
From the Department of Neurosurgery, University of Mississippi Medical Center, Jackson.
Correspondence to John H. Zhang, MD, PhD, Department of Neurosurgery, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216. E-mail jzhang{at}neurosurgery.umsmed.edu
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Background and Purpose—Our recent study showed that oxyhemoglobin (OxyHb) induces apoptosis in cultured endothelial cells. Apoptosis requires the action of various classes of proteases, including a family of cysteine proteases known collectively as the caspases. This study was undertaken to investigate the effect of 2 caspase inhibitors, Z-VDVAD-FMK and Z-DEVD-FMK, in the protection of endothelial cells from OxyHb-induced apoptosis.
Methods—Cultured bovine brain microvascular endothelial cells (passages 5 to 9) were exposed to OxyHb (10 µmol/L) for 24 to 72 hours with and without caspase inhibitors. Cell attachment, DNA ladder, Western blotting of poly(ADP-ribose) polymerase (PARP), and caspase activities were measured to confirm the cytotoxic effect of OxyHb and the protective effect of the caspase inhibitors.
Results—(1) OxyHb produced cell detachment in a time-dependent manner. (2) OxyHb increased caspase-2 and -3 activities, produced DNA ladders, and cleaved PARP in endothelial cells. (3) Z-VDVAD-FMK and Z-DEVD-FMK (100 µmol/L) attenuated OxyHb-induced cell detachment, reduced caspase-2 and -3 activities, abolished OxyHb-induced DNA ladders, and prevented OxyHb-induced cleavage of PARP.
Conclusions—OxyHb activates caspase-2 and -3 in cultured brain microvessel endothelial cells. Caspase inhibitors attenuated the cytotoxic effect of OxyHb.
Key Words: apoptosis • caspase • cerebral ischemia, transient • endothelium • oxyhemoglobins
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Endothelium in cerebral arteries contributes not only to the formation of the blood-brain barrier but also to the regulation of vascular tone. Endothelial damage is an important feature of pathological changes documented in the cerebral arteries after subarachnoid hemorrhage (SAH).1 2 3 4 5 6 Formation of craters, blebbing, and vacuolation in endothelial cells have been described in cerebral arteries after SAH, leading to the disruption of tight junctions and the detachment of endothelial cells from the internal elastic lamina and exposing basement membrane and collagen to the blood stream.1 7 Metabolic activities, such as prostaglandin metabolism, endothelial-derived relaxation factor production, and endothelin secretion, are altered, leading to changes of endothelial permeability and vascular contractility.
Oxyhemoglobin (OxyHb) is the leading cause of cerebral vasospasm.8 OxyHb produces vasoconstriction as well as cytotoxicity in smooth muscle cells and endothelial cells. Recently, several reports have documented the ability of hemoglobin to induce apoptosis in brain cell after cerebral hemorrhage.9 10 11 12 We previously reported that OxyHb induced apoptosis in cultured endothelial cells in a time- and concentration-dependent manner.13 The cytotoxic effect of OxyHb was not prevented by the voltage-dependent Ca2+ channel blocker nicardipine or by voltage-independent Ca2+ channel blockers econazole or lanthanum.14
The protease family of the caspases, the mammalian homologues of the Caenorhabditis elegans death gene, is required for mammalian apoptosis.15 Different death stimuli may activate different caspases.16 Among them, caspase-2 and caspase-3 are 2 of the important caspases in mediating apoptosis in a variety of tissues. In this study we investigated the effect of OxyHb on the activities of caspase-2 and -3 and the prophylaxis effect of caspase inhibitors on OxyHb-induced apoptosis in bovine brain microvessel endothelial cells.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Cell Lines and Reagents
Bovine brain microvascular endothelial cells were purchased from Cell Systems Corporation. Cells were cultured in CS-C Complete Medium (Cell Systems Corporation) and grown at 37°C in a humidified 5% CO2 incubator. Passages 5 through 9 were used for the experiments. During treatments with caspase inhibitors and OxyHb, the cells were incubated in CS-C Medium (Cell Systems Corporation) without growth factor and with 1% (vol/vol) fetal bovine serum.
Z-VDVAD-FMK (caspase-2 inhibitor I) and Z-DEVD-FMK (caspase-3 inhibitor II) were purchased from Calbiochem. Caspase inhibitor stock solution (20 mmol/L) was prepared in dimethyl sulfoxide (DMSO) and stored at -20°C for <1 month. The final DMSO concentrations of caspase inhibitor treatment groups (10 µmol/L, 100 µmol/L, and combined 100 µmol/L) were 0.05%, 0.5%, and 1.0% (vol/vol), respectively. Control cells received 1.0% DMSO in the cell density study and DNA ladder and 0.5% DMSO in the caspase activity study and Western blot study. These concentrations of DMSO were nontoxic to the cells, as shown in our preliminary studies. A Suicide Track DNA Ladder Isolation Kit was purchased from Oncogene Research Products. Caspase-2/ICH-1 and Caspase-3/CPP32 Colorimetric Protease Assay Kit was purchased from Medical & Biological Laboratories Co, Ltd. The Bio-Rad protein assay was purchased from Bio-Rad Laboratories. The anti-poly(ADP-ribose) polymerase (PARP) rabbit polyclonal antibody was purchased from BIOMOL Research Laboratories, Inc. The enhanced chemiluminescence system and anti-rabbit IgG antibody were purchased from Amersham Pharmacia Biotech, Inc. All other reagents were purchased from Sigma.
Preparation of OxyHb
The OxyHb was prepared according to the procedures
described by Martin et al.17
Briefly, human hemoglobin (Sigma) was reduced to OxyHb with 10-fold
molar excess of sodium dithionate. The sodium dithionate was later
removed by dialysis against 200 volumes of normal saline for 18 hours
at 4°C. The normal saline was replaced every 6 hours. The
concentration of the OxyHb was determined spectrophotometrically. OxyHb
was stored at -80°C before use.
Cell Density Assay
Cell viability was determined by counting the number
of adherent cells. The counting method was performed as previously
described18 with some
modifications. Cells were seeded at a density of
5x104 cells per well in 24-well plates.
After 2 days, the cells were preincubated with or without caspase-2 or
-3 inhibitors for 30 minutes at 37°C before final
addition of OxyHb (10 µmol/L). The cells with caspase
inhibitors and OxyHb were incubated for various periods
(24, 48, or 72 hours). After incubation, nonadherent cells were removed
by 2 washes with PBS. Adherent cells were harvested by trypsinization.
The number of cells was counted in a hemocytometer. Cell viability was
expressed as a percentage of the viable cells in experimental wells
compared with that in wells of saline control.
DNA Fragmentation Analysis (DNA
Laddering)
After incubation, the cells were scraped and
collected by centrifugation at
500g for 5 minutes at 4°C.
Genomic DNA isolation was performed as specified by the manufacturer’s
protocol (Oncogene Research Products). The extracted DNA (each 20
µg) was analyzed in a 1.5% agarose gel electrophoresis
fractionation. The gel was then examined under UV light with ethidium
bromide staining for visualization and
photographed.
Western Blot Analysis
Proteolytic cleavage of PARP was detected by Western
blot analysis as previously
described.9 After incubation,
the cells (106) were scraped and suspended
in cold PBS twice and were collected by centrifugation
at 500g for 5 minutes at 4°C.
The cells were then lysed in 1% IGEPAL CA-630, 50 mmol/L
Tris-HCl, pH 7.5, 100 mmol/L NaCl, 5 mmol/L EDTA, and 1
mmol/L phenylmethylsulfonyl fluoride for 20 minutes at 4°C;
the insoluble materials were removed by centrifugation
at 13 000g for 10 minutes at
4°C. Protein content of the lysate was quantified using Bio-Rad DC
protein assay, and 30 µg of protein on each lane was applied to 12%
SDS-PAGE. After electrophoretic transfer of the separated polypeptides
to a nitrocellulose membrane, the membranes were blocked overnight with
5% nonfat dry milk in Tween-PBS (PBS containing 0.1% Tween 20). The
membranes were washed with Tween-PBS and incubated with anti-PARP
rabbit polyclonal antibody (1:500 dilution) at room temperature for 2.5
hours. The membranes were later washed with Tween-PBS and incubated
with anti-rabbit immunoglobulin antibody linked with horseradish
peroxidase. The enhanced chemiluminescence system was used for
visualization of protein bands.
Measurement of Caspase Activity
The caspase-2/ICH-1 and caspase-3/CPP32 activities
were measured with the use of a commercially available kit (Medical &
Biological Laboratories Co, Ltd) according to the manufacturer’s
instructions. Briefly, endothelial cells were treated
with 10 µmol/L OxyHb or saline for the indicated period. After
incubation, 2x106 cells were lysed, and a
colorimetrically labeled substrate (final
concentration, 200 µmol/L),
VDVAD-p-nitroanilide
(pNA) or
DEVD-pNA, was incubated with
cell lysate at 37°C for 60 to 120 minutes. The samples were then read
with a spectrophotometer at 405 nm. Comparison of the absorbance of
pNA from a treated sample with
an untreated control allows determination of the fold increase in
caspase activity.
Data Analysis
All data are expressed as mean±SD. Statistical
significance was assessed by 1-way ANOVA with Scheffé post hoc
correction. A level of P<0.05
was considered statistically
significant.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Cell Density
Exposing endothelial cells to 10 µmol/L OxyHb caused cell detachment in a time-dependent manner. The cell viability assay showed that 69±3% of cells were attached on the plates after 24 hours of incubation with OxyHb, but only 44±3% of cells were still attached after 72 hours. Caspase inhibitors failed to protect cells at a lower concentration (10 µmol/L) but significantly prevented cell detachment at a higher concentration (100 µmol/L). A combination of both Z-VDVAD-FMK and Z-DEVD-FMK, however, did not enhance the protective effect of each caspase inhibitor (Figure 1
).
|
Caspase Activity
The activity of caspase-2 and -3 was investigated with
the use of specific colorimetrically labeled peptides,
VDVAD and DEVD, respectively. OxyHb (10 µmol/L), but not saline,
significantly enhanced caspase-2 activity after 24 hours. A similar
enhancement of caspase-2 activity was observed at 48 hours after
exposure to OxyHb. Both Z-VDVAD-FMK and Z-DEVD-FMK attenuated the
OxyHb-induced activation of caspase-2
(Figure 2A).
|
Saline induced 2.1-fold increase of caspase-3 activity after
24 hours of incubation compared with untreated cells. However, OxyHb
(10 µmol/L) induced 4.2-fold increase of caspase-3 activity, which
was significantly higher than those of either untreated or
saline-treated cells. Both Z-VDVAD-FMK and Z-DEVD-FMK
inhibitors attenuated the OxyHb-induced activation of
caspase-3
(Figure 2B
).
Since most cells died and detached 72 hours after exposure to OxyHb, the caspase-2 and caspase-3 activities were not studied. Since red-colored OxyHb might interfere with the spectrophotometric measurement, we have performed additional experiments using cells either untreated or treated with saline for 24 or 48 hours. In these studies, OxyHb was added immediately before caspase measurement so that cells were treated with OxyHb for no more than 2 minutes while OxyHb was in the solution when caspase was measured. We found that OxyHb did not increase the levels of either caspase-2 or caspase-3 (not shown).
DNA Ladder
The DNA ladder is a hallmark of apoptotic
changes. OxyHb (10 µmol/L) produced a DNA ladder after a 48-hour
incubation with endothelial cells, and this effect was
abolished by 100 µmol/L of Z-VDVAD-FMK and Z-DEVD-FMK
(Figure 3A). However, OxyHb produced DNA ladders at 72 hours
after exposure, and Z-VDVAD-FMK and Z-DEVD-FMK failed to attenuate the
effect of OxyHb
(Figure 3B).
|
PARP Cleavage
Proteolytic cleavage of PARP from a 116-kDa polypeptide
to an 85-kDa fragment is also a sensitive marker of the onset of
apoptosis. OxyHb (10 µmol/L) clearly cleaved the 116- to
85-kDa fragment after 24-hour incubation with
endothelial cells. The 116-kDa fragment almost
disappeared, and the 85-kDa fragment became clear after 48 hours of
exposure
(Figure 4A). Z-VDVAD-FMK and Z-DEVD-FMK abolished the effect
of OxyHb
(Figure 4B).
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
In eukaryotic cells, there are 2 different forms of cell death: necrosis and apoptosis.19 Necrosis is considered to be a nonphysiological cell death. Necrosis is characterized as an uncoordinated collapse of cellular homeostasis, resulting in early damage of the plasma membrane and consequently the loss of the integrity of the cell. In contrast, apoptosis is a process of programmed cell death in which unnecessary cells are eliminated from multicellular organism. In apoptotic changes, condensation of the nucleus chromatin and fragmentation of the DNA are manifested. The cell shrinks as a result of cytoplasmic condensation, and organelles preserve their normal ultrastructure. The plasma membrane becomes ruffled and blebbed, which eventually separates the cell into a number of membrane-bound fragments of different sizes. The fragments are known as "apoptotic bodies."20 Besides its normal role in the development and maintenance of proliferating mature tissue, apoptosis is also involved in abnormal processes such as cancer and degenerative diseases.21 We recently observed apoptotic changes in the endothelial cells in the middle cerebral artery of a patient who died of cerebral vasospasm after SAH.22 Endothelial cells in the spastic arteries demonstrated condensation of the nucleus chromatin in transmission electron microscopy and stained positive to terminal deoxynucleotidyl transferase–mediated dUTP-biotin nick end labeling (TUNEL) assay.
Morphological changes of apoptosis have been described for decades, and these events are considered the results of complex cellular biochemical pathways.23 In mammals, a family of cysteine proteases (caspases) appears to represent an essential component of the cell death pathway.23 24 It is believed that apoptosis is a result of the proteolysis of various cellular components initiated by activated caspases. Caspases are synthesized as proenzymes (zymogens) and activated by internal cleavage. There are currently >10 known human members of caspase.25 The caspases can be further subdivided into 3 distinct subfamilies on the basis of sequence homology: the interleukin-1ß–converting enzyme (ICE)–like family, which includes caspase-1, caspase-4, and caspase-5; the cysteine protease protein (CPP)32–like family, which includes caspase-3, caspase-6, caspase-7, caspase-8, and caspase-10; and the ICE and CED-3 homologue (ICH)–like family, which includes caspase-2 and caspase-9.26 27 Among the caspases, caspase-3 has emerged as a central player in several reports of apoptosis pathways. Caspase-3 is a potent agent of apoptosis triggered via several different pathways in a variety of mammalian cell types.25 Caspase-3 cleaves several substrates, including PARP, lamins, and actins, with resultant chromosomal DNA degradation and cellular morphological changes characteristic of apoptosis. Another important caspase-family protease is a caspase-2. A variety of apoptotic stimuli activated caspase-2 during apoptosis. This activation occurs very early on treatment of cells with apoptotic agents, and the activation of caspase-2 is not seen in cells that are resistant to apoptosis.28 These observations suggest that caspase-2 is also an indispensable agent in the pathway leading to cell death.
The present study showed that OxyHb significantly activated both caspase-2 and caspase-3 in bovine brain microvessel endothelial cells. The irreversible caspase inhibitors Z-VDVAD-FMK (caspse-2 inhibitor) and Z-DEVD-FMK (caspase-3 inhibitor) significantly reduced cell detachment, caspase-2 and -3 activities, DNA ladders, and proteolytic cleavage of PARP. These results strongly suggest that activation of caspase-2 and caspase-3 is essential for OxyHb-induced apoptosis in endothelial cells, and Z-VDVAD-FMK and Z-DEVD-FMK have the potential to protect cells. Since both Z-VDVAD-FMK and Z-DEVD-FMK have almost equal and partial effects, other pathways might be involved in OxyHb-induced cell death.
This speculation is supported by the following observations in our study. First, caspase inhibitors have cross actions: Z-VDVAD-FMK reduced caspase-3 activity, and Z-DEVD-FMK reduced caspase-2 activity. Second, a combination of caspase inhibitors failed to result in a synergistic effect. The relation between caspase-2 and -3 is not clear. Caspase-3 may be an activator of caspase-2 in one study29 and be activated by caspase-2 in another.28 Third, neither of the caspase inhibitors is exclusively selective only for caspase-2 or -3; they also inhibit other caspases. Thus, even though caspase-2 and -3 activities were increased markedly by OxyHb, we cannot exclude the possible involvement of other caspases.
Most investigators used a moderate concentration of OxyHb (1 to 100 µmol/L) in the cytotoxicity studies. OxyHb (1 to 100 µmol/L) produced detachment and cell death and apoptotic changes in cultured endothelial cells.13 30 31 A higher concentration of OxyHb was used in several studies in either in vitro or in vivo animal models. For example, 780 µmol/L hemoglobin (50% OxyHb)32 and 190 µmol/L ferrous hemoglobin33 were used in monkey models of vasospasm. The actual concentration of OxyHb and deoxyhemoglobin in the blood clot on day 7 was approximately 70 µmol/L.34 However, even though the concentration of OxyHb was high in the extraluminal space, the concentration of OxyHb may have been low in the intraluminal space closed to endothelial cells. It is unlikely that OxyHb from a blood clot can reach endothelial cells at higher levels. We used a moderate concentration of OxyHb (10 µmol/L) but incubated cells for 2 to 3 days in this study to more closely resemble conditions in patients after SAH.
A question that remains to be answered is the mechanism of OxyHb-induced apoptosis in endothelial cells. Two factors most likely responsible for the cytotoxic action of OxyHb are an elevation of intracellular Ca2+ and the generation of free radicals. Many apoptosis producers increase Ca2+ concentration, and the alteration of Ca2+ has been linked to apoptosis in a number of experimental models. Ca2+ regulates several key steps in the apoptotic pathway, from early signaling events to the chromatin cleavage that appears to mark an irreversible commitment to cell death in different cell types.35 36 However, our recent study failed to prove that Ca2+ was involved in OxyHb-induced apoptosis in endothelial cells. None of the Ca2+ channel blockers, such as nicardipine, econazole, or lanthanum, prevented apoptosis; on the contrary, econazole and lanthanum enhanced the cytotoxic effect of OxyHb, probably by causing Ca2+ starvation.14 Another possible route for Ca2+ elevation is release of Ca2+ from internal stores. Future studies are needed to examine this possibility.
Another possible mechanism is free radical generation. The autoxidation of OxyHb to methemoglobin generates active species of oxygen. These include the superoxide ion, the hydroxyl radical, which is formed by the reaction of bivalent iron with hydrogen peroxide, and other active forms of oxygen, such as the ferryl ion, the perferryl ion, and the peroxyradical.37 Reactive oxygen species have been implicated as mediators of apoptosis38 39 40 and are considered to be involved in caspase-3 activation.41 The possible role of free radicals in OxyHb-induced apoptosis in endothelial cells requires further investigation.
Another possible candidate is nitric oxide (NO). NO is produced by NO synthase (NOS) and released either from endothelial cells (eNOS) or from neuronal tissues (nNOS). NO is involved in disparate functions, including vasorelaxation, and plays an important role in regulation of cerebral vascular tone.42 NO has been found to promote apoptosis in myocytes, pancreatic islet cells, macrophage-like cells, certain tumors, neuronal cells, and vascular smooth muscle cells.43 44 In contrast, NO has also been reported to inhibit apoptosis in other cells, including vascular endothelial cells.45 The mechanisms responsible for these marked differences in the responses to NO have not been clearly defined. However, there are several arguments against a role of NO in OxyHb-induced apoptosis. First, OxyHb binds NO with high affinity, and it may decrease the concentration of NO in the cerebral arterial wall after SAH. Second, the endothelial NOS concentration and the endothelial NOS messenger RNA in cerebral arteries after experimental SAH also tend to decrease during the chronic stage.42 46 All these might reduce a potential role of NO in OxyHb-induced apoptosis in vascular endothelial cells.
Apoptosis may play an important role in cerebral vasospasm. Apoptotic endothelial death may destroy the blood-brain barrier and expose smooth muscle cells to vasoconstrictors in the blood flow. The smooth muscle layer might be exposed to neurotransmitters, toxins, and other vasoactive agents in the blood stream through the damaged endothelium barrier, followed by an enhanced response of vessel contraction. Damaged endothelial cells decrease the generation and release of vasodilators, such as NO and prostacyclin, from these cells.7 Furthermore, damaged endothelial cells may initiate thrombogenesis, cause thrombotic embolic infarction, and worsen the ischemic symptom of cerebral vasospasm. Hence, direct damage of the endothelial cells is considered responsible for the pathogenesis of cerebral vasospasm after SAH. Recent investigations show that apoptosis occurred in global or local cerebral ischemia,47 and inhibition of caspases prevents apoptosis in neurons and endothelial cells.48 49 50
We demonstrated that caspase inhibitors prevented OxyHb-induced endothelial apoptosis in cultured bovine brain endothelial cells. Thus, caspase inhibitors may be useful in the treatment of cerebral vasospasm after SAH. In addition, caspase inhibitors may not only prevent apoptosis in endothelial cells but also protect brain tissues against apoptosis caused by cerebral ischemia during cerebral vasospasm.
|
Acknowledgments |
|---|
This study was supported in part by a grant from the American Heart Association Bugher Foundation for Stroke Award (to Dr Zhang). We thank Dr He Zhu for helpful technical advice.
Received July 24, 2000; revision received September 12, 2000; accepted October 2, 2000.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
1. Findlay JM, Weir BK, Kanamaru K, Espinosa F. Arterial wall changes in cerebral vasospasm. Neurosurgery. 1989;25:736–745.[Medline] [Order article via Infotrieve]
2. Kajikawa H, Ohta T, Yoshikawa Y, Funatsu N, Yamamoto M, Someda K. Cerebral vasospasm and hemoglobins: clinical and experimental studies. Neurol Med Chir (Tokyo). 1979;19:61–71.[Medline] [Order article via Infotrieve]
3.
Kassell NF, Sasaki
T, Colohan AR, Nazar G. Cerebral vasospasm following aneurysmal
subarachnoid hemorrhage.
Stroke. 1985;16:562–572.
4. Mayberg MR, Okada T, Bark DH. The significance of morphological changes in cerebral arteries after subarachnoid hemorrhage. J Neurosurg. 1990;72:626–633.[Medline] [Order article via Infotrieve]
5. Sasaki T, Kassell NF, Yamashita M, Fujiwara S, Zuccarello M. Barrier disruption in the major cerebral arteries following experimental subarachnoid hemorrhage. J Neurosurg. 1985;63:433–440.[Medline] [Order article via Infotrieve]
6. Zuccarello M, Kassell NF, Sasaki T, Fujiwara S, Nakagomi T, Lehman RM. Barrier disruption in the major cerebral arteries after experimental subarachnoid hemorrhage in spontaneously hypertensive and normotensive rats. Neurosurgery. 1987;21:515–522.[Medline] [Order article via Infotrieve]
7. Mayberg MR. Cerebral vasospasm. Neurosurg Clin N Am. 1998;9:615–627.[Medline] [Order article via Infotrieve]
8.
Macdonald RL, Weir
BK. A review of hemoglobin and the pathogenesis of cerebral vasospasm.
Stroke. 1991;22:971–982.
9. Matz PG, Fujimura M, Chan PH. Subarachnoid hemolysate produces DNA fragmentation in a pattern similar to apoptosis in mouse brain. Brain Res. 2000;858:312–319.[Medline] [Order article via Infotrieve]
10. Matsushita K, Meng W, Wang X, Asahi M, Asahi K, Moskowitz MA, Lo EH. Evidence for apoptosis after intercerebral hemorrhage in rat striatum. J Cereb Blood Flow Metab. 2000;20:396–404.[Medline] [Order article via Infotrieve]
11. Xue M, Del Bigio MR. Intracerebral injection of autologous whole blood in rats: time course of inflammation and cell death. Neurosci Lett. 2000;283:230–232.[Medline] [Order article via Infotrieve]
12.
Xue M, Del Bigio
MR. Intracortical hemorrhage injury in rats: relationship
between blood fractions and brain cell death.
Stroke. 2000;31:1721–1727.
13. Ogihara K, Zubkov AY, Bernanke DH, Lewis AI, Parent AD, Zhang JH. Oxyhemoglobin-induced apoptosis in cultured endothelial cells. J Neurosurg. 1999;91:459–465.[Medline] [Order article via Infotrieve]
14. Meguro T, Klett CPR, Chen B, Parent AD, Zhang JH. Role of Ca2+ channels in oxyhemoglobin-induced apoptosis in endothelial cells. J Neurosurg. 2000;93:650–656.
15. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell. 1993;75:641–652.[Medline] [Order article via Infotrieve]
16. Choi KS, Lim IK, Brady JN, Kim SJ. ICE-like protease (caspase) is involved in transforming growth factor beta1-mediated apoptosis in FaO rat hepatoma cell line. Hepatology. 1998;27:415–421.[Medline] [Order article via Infotrieve]
17.
Martin W, Villani
GM, Jothianandan D, Furchgott RF. Selective blockade of
endothelium-dependent and glyceryl trinitrate-induced
relaxation by hemoglobin and by methylene blue in the rabbit aorta.
J Pharmacol Exp Ther. 1985;232:708–716.
18. Lieberthal W, Triaca V, Koh JS, Pagano PJ, Levine JS. Role of superoxide in apoptosis induced by growth factor withdrawal. Am J Physiol. 1998;275:F691–F702.
19. Searle J, Kerr JF, Bishop CJ. Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol Annu. 1982;17:229–259.
20. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–257.[Medline] [Order article via Infotrieve]
21.
Thompson CB.
Apoptosis in the pathogenesis and treatment of disease.
Science. 1995;267:1456–1462.
22. Zubkov AY, Ogihara K, Bernanke DH, Parent AD, Zhang J. Apoptosis of endothelial cells in vessels affected by cerebral vasospasm. Surg Neurol. 2000;53:260–266.[Medline] [Order article via Infotrieve]
23. Vaux DL, Korsmeyer SJ. Cell death in development. Cell. 1999;96:245–254.[Medline] [Order article via Infotrieve]
24. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell. 1993;75:653–660.[Medline] [Order article via Infotrieve]
25. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J. Human ICE/CED-3 protease nomenclature. Cell. 1996;87:171.[Medline] [Order article via Infotrieve]
26. Takahashi A, Earnshaw WC. ICE-related proteases in apoptosis. Curr Opin Genet Dev. 1996;6:50–55.[Medline] [Order article via Infotrieve]
27. Zhivotovsky B, Burgess DH, Vanags DM, Orrenius S. Involvement of cellular proteolytic machinery in apoptosis. Biochem Biophys Res Commun. 1997;230:481–488.[Medline] [Order article via Infotrieve]
28.
Harvey NL, Butt
AJ, Kumar S. Functional activation of Nedd2/ICH-1 (caspase-2) is an
early process in apoptosis. J
Biol Chem. 1997;272:13134–13139.
29.
Li H, Bergeron L,
Cryns V, Pasternack MS, Zhu H, Shi L, Greenberg A, Yuan J. Activation
of caspase-2 in apoptosis. J
Biol Chem. 1997;272:21010–21017.
30. Comair YG, Schipper HM, Brem S. The prevention of oxyhemoglobin-induced endothelial and smooth muscle cytoskeletal injury by deferoxamine. Neurosurgery. 1993;32:58–64.[Medline] [Order article via Infotrieve]
31.
Takenaka K,
Kassell NF, Foley PL, Lee KS. Oxyhemoglobin-induced cytotoxicity and
arachidonic acid release in cultured bovine
endothelial cells.
Stroke. 1993;24:839–845.
32. Macdonald RL, Weir BK, Runzer TD, Grace MG, Findlay JM, Saito K, Cook DA, Mielke BW, Kanamaru K. Etiology of cerebral vasospasm in primates. J Neurosurg. 1991;75:415–424.[Medline] [Order article via Infotrieve]
33. Macdonald RL, Weir BK, Zhang J, Marton LS, Sajdak BA, Johns LM. Adenosine triphosphate and hemoglobin in vasospastic monkeys. Neurosurg Focus. 1997;3:article 3.
34. Pluta RM, Afshar JK, Boock RJ, Oldfield EH. Temporal changes in perivascular concentrations of oxyhemoglobin, deoxyhemoglobin, and methemoglobin after subarachnoid hemorrhage. J Neurosurg. 1998;88:557–561.[Medline] [Order article via Infotrieve]
35. McConkey DJ, Orrenius S. The role of calcium in the regulation of apoptosis. Biochem Biophys Res Commun. 1997;239:357–366.[Medline] [Order article via Infotrieve]
36. Trump BF, Berezesky IK. The role of altered [Ca2+]i regulation in apoptosis, oncosis, and necrosis. Biochim Biophys Acta. 1996;1313:173–178.[Medline] [Order article via Infotrieve]
37.
Misra HP,
Fridovich I. The generation of superoxide radical during the
autoxidation of hemoglobin. J Biol
Chem. 1972;247:6960–6962.
38. Jacobson MD, Raff MC. Programmed cell death and Bcl-2 protection in very low oxygen. Nature. 1995;374:814–816.[Medline] [Order article via Infotrieve]
39.
Johnson TM, Yu ZX,
Ferrans VJ, Lowenstein RA, Finkel T. Reactive oxygen species are
downstream mediators of p53-dependent apoptosis.
Proc Natl Acad Sci
U S A. 1996;93:11848–11852.
40.
Kane DJ, Sarafian
TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T, Bredesen DE. Bcl-2
inhibition of neural death: decreased generation of reactive oxygen
species. Science. 1993;262:1274–1277.
41. Hampton MB, Orrenius S. Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett. 1997;414:552–556.[Medline] [Order article via Infotrieve]
42. Pluta RM, Thompson BG, Dawson TM, Snyder SH, Boock RJ, Oldfield EH. Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg. 1996;84:648–654.[Medline] [Order article via Infotrieve]
43. Pinsky DJ, Aji W, Szabolcs M, Athan ES, Liu Y, Yang YM, Kline RP, Olson KE, Cannon PJ. Nitric oxide triggers programmed cell death (apoptosis) of adult rat ventricular myocytes in culture. Am J Physiol. 1999;277:H1189–H1199.
44. Uehara T, Kikuchi Y, Nomura Y. Caspase activation accompanying cytochrome c release from mitochondria is possibly involved in nitric oxide-induced neuronal apoptosis in SH-SY5Y cells. J Neurochem. 1999;72:196–205.[Medline] [Order article via Infotrieve]
45.
Dimmeler S,
Haendeler J, Nehls M, Zeiher AM. Suppression of apoptosis by
nitric oxide via inhibition of interleukin-1beta-converting enzyme
(ICE)-like and cysteine protease protein (CPP)-32-like proteases.
J Exp Med. 1997;185:601–607.
46. Hino A, Tokuyama Y, Weir B, Takeda J, Yano H, Bell GI, Macdonald RL. Changes in endothelial nitric oxide synthase mRNA during vasospasm after subarachnoid hemorrhage in monkeys. Neurosurgery. 1996;39:562–567.[Medline] [Order article via Infotrieve]
47. MacManus JP, Linnik MD. Gene expression induced by cerebral ischemia: an apoptotic perspective. J Cereb Blood Flow Metab. 1997;17:815–832.[Medline] [Order article via Infotrieve]
48.
Chen J, Nagayama
T, Jin K, Stetler RA, Zhu RL, Graham SH, Simon RP. Induction of
caspase-3-like protease may mediate delayed neuronal death in the
hippocampus after transient cerebral ischemia.
J Neurosci. 1998;18:4914–4928.
49.
Hara H,
Friedlander RM, Gagliardini V, Ayata C, Fink K, Huang Z,
Shimizu-Sasamata M, Yuan J, Moskowitz MA. Inhibition of interleukin
1beta converting enzyme family proteases reduces ischemic and
excitotoxic neuronal damage. Proc Natl
Acad Sci
U S A. 1997;94:2007–2012.
50. Harrison-Shostak DC, Lemasters JJ, Edgell CJ, Herman B. Role of ICE-like proteases in endothelial cell hypoxic and reperfusion injury. Biochem Biophys Res Commun. 1997;231:844–847. [Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  S. Park, M. Yamaguchi, C. Zhou, J.W. Calvert, J. Tang, and J. H. Zhang Neurovascular Protection Reduces Early Brain Injury After Subarachnoid Hemorrhage Stroke, October 1, 2004; 35(10): 2412 - 2417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, T. Mori, T. Sumii, and E. H. Lo Hemoglobin-Induced Cytotoxicity in Rat Cerebral Cortical Neurons: Caspase Activation and Oxidative Stress Stroke, July 1, 2002; 33(7): 1882 - 1888. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||